LOAN AND SECURITY AGREEMENT No. V13111Loan and Security Agreement • December 23rd, 2013 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledDecember 23rd, 2013 Company Industry JurisdictionThis Loan and Security Agreement (this “Loan Agreement”), made as of September 30, 2013 by and between Ares Capital Corporation (“Lender”), with offices at 245 Park Avenue, 44th Floor, New York, NY 10167, and Genocea Biosciences, Inc. (“Borrower”), a Delaware corporation with its principal place of business at 100 Acorn Park Drive, 5th Floor, Cambridge, MA 02140.
LOAN AND SECURITY AGREEMENT No. V13111Loan and Security Agreement • October 23rd, 2013 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledOctober 23rd, 2013 Company Industry JurisdictionThis Loan and Security Agreement (this “Loan Agreement”), made as of September 30, 2013 by and between Ares Capital Corporation (“Lender”), with offices at 245 Park Avenue, 44th Floor, New York, NY 10167, and Genocea Biosciences, Inc. (“Borrower”), a Delaware corporation with its principal place of business at 100 Acorn Park Drive, 5th Floor, Cambridge, MA 02140.
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT No. V06205Loan and Security Agreement • September 14th, 2007 • Varolii CORP • Illinois
Contract Type FiledSeptember 14th, 2007 Company JurisdictionThis Amended and Restated Loan and Security Agreement (this “Loan Agreement”), made as of April 28, 2006, and as amended and restated as of July 20, 2007, by and between BlueCrest Venture Finance Master Fund Limited, as assignee of Ritchie Debt Acquisition Fund, Ltd., as assignee of RAM Opportunity Fund I, L.L.C., (“Lender”), c/o BlueCrest Capital Finance, L.P., 225 West Washington Street, Chicago, IL 60606, and Varolii Corporation, formerly known as PAR3 Communications, Inc. (“Borrower”), a Washington corporation with its principal place of business at 821 Second Avenue, Suite 1000 – 10th Floor, Seattle, WA 98104.